We can’t outpace a 21st century outbreak with a 1940s vaccine technology. It’s foolish to even think we can & not aggressively accelerate development of new approaches.

Rob Stein NPR Luciana Borio, MD Michael Osterholm Jennifer Nuzzo, DrPH Dawn O'Connell The White House CEPI CDC…

“…if the low level of mammalian adaptations they're seeing become dominant, the risk of interspecies transmission will be higher.” #H5flu

With respect to #H5flu “First…eliminate the happy talk.” And “we need to be more humble.” ⁦Michael Osterholm⁩ ⁦Rick Bright⁩ ⁦Jennifer Nuzzo, DrPH⁩ npr.org/sections/healt…

👀US-based vet said that there is underreporting of H5N1 infections in farm workers

'every dairy that I've worked with has – with the exception of one – had sick human beings at the same time they had sick cows'

bovinevetonline.com/news/industry/…

“a novel H5N1 reassortant seen in poultry in Cambodia, Laos, & Vietnam over the past 2 years has now been detected in humans..The virus contains surface proteins from an older H5N1 clade (2.3.2.1c) & internal genes from the more recent 2.3.4.4b H5N1 clade” cidrap.umn.edu/avian-influenz…

Congratulations. We have long suspected that patients aren’t always getting the most appropriate antibiotics. Cost containment is important. Antibiotic stewardship is important. Cost containment disguised as antibiotic stewardship is not ok.

Gain insights from biologics and public health experts speaking at the upcoming #CarterExchange24 such as Luciana Borio, MD, Venture Partner at ARCH Venture Partners!

Find more info: bit.ly/4c0mH08

H5N1 bird flu in U.S. cattle: A wake-up call to action statnews.com/2024/04/12/h5n… via STAT Philip R. Krause, M.D. and I argue that “comparisons to seasonal flu management underestimate the unique challenges posed by H5N1”

I hope the new team at the The White House Office of Pandemic Preparedness and Response doesn’t think we are prepared.

Spending on Targeted Therapies for Duchenne Muscular Dystrophy | Neurology | JAMA | JAMA Network - I wonder why the trials have been delayed. jamanetwork.com/journals/jama/…

Many great points. See steve usdin prescription for U.S. prosperity in biotech.
It’s time to get real about U.S. biocompetitiveness  biocentury.com/article/651695…

If you have time to listen to only one interview or podcast, this is it: steve usdin interviewing Robert Nelsen I wish they kept going for longer.

It was a pleasure to join Jaime Yassif James Diggans pdmillett Weiwen Zhang Ernest Moniz and the NTI team at #MSC2024 for the launch of IBBIS...biosecurity is a collective responsibility.

Tragic. 😢

Absolutely thrilled to see the The White House launch the Clinical Trials Readiness initiative whitehouse.gov/ostp/news-upda… The need for better, simpler, faster, and more representative trials is why paradigm.inc was created. #ClinicalTrials #Innovation #HealthcareRevolution

Our last group of speakers at today's Board of Advisors meeting @drewendy.bsky.social and Luciana Borio, MD discussed the future of biotechnology.

As happens more often than not, I find myself agreeing w/ Luciana Borio, MD The possibilities of biotech & life science feel endless right now. And it is the perfect time to chart a course that thinks about ethics, security, equity, safety, & the #bioeconomy

We must do prepare for biothreats and pandemics. Congress and the Administration can't just wish these threats away.

I'm adding #NewHampshire to my bucket list of places to visit. Amazing work by Tom Bollyky and @ThinkGlobalHlthteam at Council on Foreign Relations

Great piece by Rick Bright on Think Global Health Question: Would the U.S. be as quick as Cambodia? thinkglobalhealth.org/article/avian-…